Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Cancer Survival Analysis01:21

Cancer Survival Analysis

334
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
334

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Increased MASH-associated liver cancer in younger demographics.

Hepatology communications·2025
Same author

Mortality of Gastrointestinal Cancers Attributable to Smoking, Alcohol, and Metabolic Risk Factors, and its Association With Socioeconomic Development Status 2000-2021.

The American journal of medicine·2025
Same author

Alcohol-Related Liver Disease, Followed by Metabolic Dysfunction-Associated Steatotic Liver Disease, Emerges as the Fastest-Growing Aetiologies for Primary Liver Cancer in the United States.

Alimentary pharmacology & therapeutics·2025
Same author

Do Risk Factors for HCC Impact the Association of CT/MRI LIRADS Major Features With HCC? An Individual Participant Data Meta-Analysis.

Canadian Association of Radiologists journal = Journal l'Association canadienne des radiologistes·2024
Same author

Hepatocellular carcinoma: updates on epidemiology, surveillance, diagnosis and treatment.

Clinical and molecular hepatology·2024
Same author

Value of HCC surveillance in a landscape of emerging surveillance options: Perspectives of a multi-stakeholder modified Delphi panel.

Hepatology (Baltimore, Md.)·2024

相关实验视频

Updated: Jun 17, 2025

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
06:46

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Published on: September 27, 2024

239

比较SEER和NCDB:使用结直肠癌的案例研究.

Po-Hong Liu1, Sandi L Pruitt2, Amit G Singal3

  • 1Division of Digestive and Liver Diseases, Department of Medicine, University of Texas Southwestern Medical Center, 5959 Harry Hines Blvd, Suite 520U, Dallas, TX, 75235, USA. stuartliu@gmail.com.

Cancer causes & control : CCC
|August 6, 2024
PubMed
概括

通过比较来自监测,流行病学和最终结果 (SEER) 计划和国家癌症数据库 (NCDB) 的癌症数据,可以发现明显的优势. SEER提供详细的人口和社会经济数据,而NCDB在癌症研究的特定瘤和治疗信息方面表现出色.

关键词:
结肠直肠癌是一种癌症.流行病学 流行病学没有NCDBB的情况.塞尔·塞尔 (Seer) 是一个看得见的人.

更多相关视频

Development of Compendium for Esophageal Squamous Cell Carcinoma
03:36

Development of Compendium for Esophageal Squamous Cell Carcinoma

Published on: April 12, 2024

393
Clinical Application of Single-Surgeon, Three-Port, Laparoscopic Resection for Colorectal Cancer with Natural Orifice Specimen Extraction
08:26

Clinical Application of Single-Surgeon, Three-Port, Laparoscopic Resection for Colorectal Cancer with Natural Orifice Specimen Extraction

Published on: March 24, 2023

434

相关实验视频

Last Updated: Jun 17, 2025

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
06:46

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Published on: September 27, 2024

239
Development of Compendium for Esophageal Squamous Cell Carcinoma
03:36

Development of Compendium for Esophageal Squamous Cell Carcinoma

Published on: April 12, 2024

393
Clinical Application of Single-Surgeon, Three-Port, Laparoscopic Resection for Colorectal Cancer with Natural Orifice Specimen Extraction
08:26

Clinical Application of Single-Surgeon, Three-Port, Laparoscopic Resection for Colorectal Cancer with Natural Orifice Specimen Extraction

Published on: March 24, 2023

434

科学领域:

  • 在瘤学瘤学.
  • 癌症流行病学 癌症流行病学
  • 医疗保健服务研究 医疗服务研究

背景情况:

  • 全国癌症登记,如监测,流行病学和最终结果 (SEER) 计划和国家癌症数据库 (NCDB),对于美国的癌症研究至关重要.
  • 了解SEER和NCDB的独特优势和局限性对于强大的研究设计和癌症趋势和结果的准确解释至关重要.
  • 结肠直肠癌 (CRC) 作为一个有价值的案例研究来比较这两个主要的癌症数据库的数据丰富性和覆盖范围.

研究的目的:

  • 以结直肠癌 (CRC) 为模型,对监测,流行病学和最终结果 (SEER) 计划和国家癌症数据库 (NCDB) 进行比较分析.
  • 评估SEER和NCDB之间癌症研究可用的人口,临床,治疗和区域级数据的差异.
  • 为研究人员提供有关针对特定癌症研究问题的最佳数据库选择的信息.

主要方法:

  • 利用了来自监测,流行病学和最终结果 (SEER) 计划 (n=575,128) 和国家癌症数据库 (NCDB) (n=1,578,046) 的结直肠癌 (CRC) 患者数据,这些患者在2004年至2021年期间被诊断出癌症.
  • 比较了两个数据集之间的关键患者特征,包括年龄,瘤位置,阶段和治疗分布.
  • 评估了特定数据元素的可用性,例如种族/民族多样性,区域级社会经济因素,瘤分子标记物和治疗细节.

主要成果:

  • 人口和临床特征 (年龄,瘤位置,阶段,治疗) 在结直肠癌的SEER和NCDB之间是可比的.
  • 在SEER中,西班牙裔和亚洲/太平洋岛民的比例更高,并且包含了更多的区域级社会经济数据.
  • NCDB提供了更详细的瘤特征 (例如,微卫星不稳定性,KRAS突变) 和治疗结果 (例如,30天死亡率,再接收),而SEER独特地提供了年龄调整的发病率,死亡率和特定原因生存率.

结论:

  • SEER和NCDB都是癌症研究的宝贵资源,但它们提供了互补的数据优势.
  • 对于研究人口水平差异,社会经济因素以及发病率/死亡率趋势的研究来说,SEER是有利的.
  • NCDB更适合研究治疗有效性,分子特征和详细的外科治疗结果.